For over 20 years, NIAID has funded the Sexual Awareness for Everyone (SAFE) study at The University of Texas Health Science Center San Antonio to reduce risky behaviors that often lead to sexually transmitted diseases.
Volunteer for NIAID-funded clinical studies related to gonorrhea on ClinicalTrials.gov.
Gonorrhea is one of the most common sexually transmitted diseases in the United States, where more than 800,000 gonorrhea infections are estimated to occur each year. Although some men and women may have symptoms (such as discharge or burning when urinating), most people infected with gonorrhea do not. As a result, many infections go undetected and untreated. Left untreated, gonorrhea can cause serious health problems, particularly for women, including chronic pelvic pain, life-threatening ectopic pregnancy and infertility. Gonorrhea infection also increases a person’s risk of contracting and transmitting HIV.
NIAID supports a comprehensive, multidisciplinary program of research on Neisseria gonorrhoeae (gonococci). Researchers are trying to understand how gonococci infect cells while evading defenses of the human immune system. Studies are ongoing to find
More NIAID Research on Gonorrhea
Antimicrobial (Drug) Resistance in Neisseria gonorrhoeae (Gonorrhea)
Two New Promising Treatment Regimens for Gonorrhea—July 15, 2013
Last Updated July 18, 2013
Last Reviewed January 07, 2011